These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20823283)

  • 21. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
    Vermitsky JP; Edlind TD
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis.
    Charlier C; El Sissy C; Bachelier-Bassi S; Scemla A; Quesne G; Sitterlé E; Legendre C; Lortholary O; Bougnoux ME
    Antimicrob Agents Chemother; 2016 Jan; 60(1):662-5. PubMed ID: 26525799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
    Hull CM; Bader O; Parker JE; Weig M; Gross U; Warrilow AG; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6417-21. PubMed ID: 23027188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Various cytosine/adenine permease homologues are involved in the toxicity of 5-fluorocytosine in Saccharomyces cerevisiae.
    Paluszynski JP; Klassen R; Rohe M; Meinhardt F
    Yeast; 2006 Jul; 23(9):707-15. PubMed ID: 16845689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.
    Biswas C; Chen SC; Halliday C; Martinez E; Rockett RJ; Wang Q; Timms VJ; Dhakal R; Sadsad R; Kennedy KJ; Playford G; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29364212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing.
    Spettel K; Barousch W; Makristathis A; Zeller I; Nehr M; Selitsch B; Lackner M; Rath PM; Steinmann J; Willinger B
    PLoS One; 2019; 14(1):e0210397. PubMed ID: 30629653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta-analysis.
    Bienvenu AL; Leboucher G; Picot S
    Mycoses; 2019 Sep; 62(9):835-846. PubMed ID: 31077631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.
    Khalifa HO; Arai T; Majima H; Watanabe A; Kamei K
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
    Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
    Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
    Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic Basis of pH-Dependent 5-Flucytosine Resistance in Aspergillus fumigatus.
    Gsaller F; Furukawa T; Carr PD; Rash B; Jöchl C; Bertuzzi M; Bignell EM; Bromley MJ
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.
    Arastehfar A; Daneshnia F; Salehi M; Yaşar M; Hoşbul T; Ilkit M; Pan W; Hagen F; Arslan N; Türk-Dağı H; Hilmioğlu-Polat S; Perlin DS; Lass-Flörl C
    Mycoses; 2020 Sep; 63(9):911-920. PubMed ID: 32413170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review on Molecular Mechanisms of Antifungal Resistance in
    Lotfali E; Fattahi A; Sayyahfar S; Ghasemi R; Rabiei MM; Fathi M; Vakili K; Deravi N; Soheili A; Toreyhi H; Shirvani F
    Microb Drug Resist; 2021 Oct; 27(10):1371-1388. PubMed ID: 33956513
    [No Abstract]   [Full Text] [Related]  

  • 35. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling.
    Nabili M; Abdollahi Gohar A; Badali H; Mohammadi R; Moazeni M
    J Glob Antimicrob Resist; 2016 Jun; 5():42-6. PubMed ID: 27436465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
    Whaley SG; Zhang Q; Caudle KE; Rogers PD
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.
    Hope WW; Warn PA; Sharp A; Howard S; Kasai M; Louie A; Walsh TJ; Drusano GL; Denning DW
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3680-8. PubMed ID: 16954320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity of FCY2 leading to the development of flucytosine resistance in Candida tropicalis.
    Chen YN; Lo HJ; Wu CC; Ko HC; Chang TP; Yang YL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2506-14. PubMed ID: 21422221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiae.
    Costa C; Ponte A; Pais P; Santos R; Cavalheiro M; Yaguchi T; Chibana H; Teixeira MC
    PLoS One; 2015; 10(8):e0135110. PubMed ID: 26267134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter.
    Noël T; François F; Paumard P; Chastin C; Brèthes D; Villard J
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1275-84. PubMed ID: 12654658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.